Table 1.

Clinical characteristics of individuals undergoing bariatric surgery.

	N	pre-surgery	N	post-surgery	delta post-pre	P post vs pre
Sex (female/male)	6/3
Age (years)	9	52.2 [25.9; 63.9]	9	55.5 [27.5; 65.5]	1.6 [0.8; 6.7]
BMI (kg/m2)	9	54.0 [43.0; 71.7]	9	39.8 [30.9; 44.7]	−15.2 [−37.5; −9.4]	3.9 x 10−3
bodyfat (%)	9	49.1 [35.5; 64.1]	8	41.2 [10.0; 63.3]	−6.5 [−25.5; 8.6]	0.08
CRP (μg/mL)	9	10.0 [3.1; 18.1]	9	0.9 [0.6; 9.9]	−3.9 [−13.8;-2.1]	0.004
HbA1c (%)	9	5.6 [4.7; 7.9]	8	5.5 [5.0; 7.3]	−0.6 [−0.7; 1.1]	0.20
FPG (mmol/L)	9	5.9 [5.4; 7.8]	9	5.3 [4.5; 8.4]	−0.2 [−2.3; 1.9]	0.57
FPI (pmol/L)	9	201.1 [97.8; 487.8]	7	117.5 [24.9; 378.9]	−49.8 [−188.7; 177.8]	0.69
HOMA-IR	9	7.0 [3.3; 20.7]	6	3.2 [0.8; 15.8]	−0.9 [−6.2; 7.8]	1
Triglycerides mmol/L)	9	1.6 [1.1; 3.5]	6	1.1 [0.6; 2.0]	−0.3 [−1.3; 0.7]	0.22
Cholesterol (mmol/L)	9	4.7 [3.4; 5.5]	6	3.9 [3.5; 5.2]	−0.6 [−1.0; 0.2]	0.06
LDL-cholesterol (mmol/L)	9	3.1 [2.1; 3.8]	6	2.6 [1.8; 3.4]	−0.4 [−1.7; 0.03]	0.06
HDL-cholesterol (mmol/L)	9	0.9 [0.7; 1.2]	6	1.2 [1.0; 1.5]	0.3 [0.05; 0.6]	0.03
ALAT (μkat/L)	9	0.7 [0.3; 2.0]	9	0.3 [0.2; 1.4]	−0.2 [−1.8; 0.5]	0.07
ASAT (μkat/L)	9	0.5 [0.4; 1.0]	9	0.4 [0.3; 0.9]	−0.1 [−0.7; 0.4]	0.30
gGT (μkat/L)	9	0.7 [0.3; 0.8]	9	0.3 [0.1; 2.3]	−0.2 [−0.5; 1.4]	0.13

Values are shown as median [min; max] P: significance levels based on Wilcoxon signed rank test. Significant P (<0.05) are marked bold. ALAT: alanine aminotransferase; ASAT: aspartate aminotransferase; BMI: body mass index; CRP: C reactive protein; FPG: fasting plasma glucose; FPI: fasting plasma insulin; gGT: gamma-glutamyl transferase; HbA1c: glycated haemoglobin A1c; HDL: high density lipoprotein; HOMA-IR: homeostatic model assessment for insulin resistance; LDL: low density lipoprotein.